Tesamorelin: The Peptide for Visceral Fat Reduction — Evidence and Use
An honest medical review of Tesamorelin (Egrifta): GHRH mechanism, clinical evidence for visceral fat, dosing, contraindications, and COFEPRIS regulation.
Cargando…
Loading, please waitAn honest medical review of Tesamorelin (Egrifta): GHRH mechanism, clinical evidence for visceral fat, dosing, contraindications, and COFEPRIS regulation.
An honest review of TB-500 (synthetic thymosin beta-4): mechanism, 2026 clinical evidence, comparison with BPC-157, dosing, and COFEPRIS regulation.
An honest medical review of Sermorelin: GHRH 1-29 analog, clinical evidence, typical dosing, comparison with CJC-1295, and COFEPRIS regulation in Mexico.
An honest medical review of Selank: nootropic heptapeptide, anxiolytic mechanism, clinical evidence (largely Russian), intranasal dosing, and COFEPRIS context.
An honest medical review of PT-141 (bremelanotide): CNS mechanism, clinical evidence, comparison with PDE5 inhibitors, dosing, and Mexican regulation.
An honest medical guide to peptide therapy safety: side-effect profiles by category, risks from unregulated sources, and why medical supervision matters.
How stem cells, PRP, and peptides complement each other in personalized regenerative protocols: clinical use cases, synergies, and precautions.
What CJC-1295 and Ipamorelin are, how the GH secretagogue stack works, clinical evidence, typical dosing, and COFEPRIS regulatory context.
An honest medical review of AOD-9604 (hGH 176-191 fragment): mechanism, limited clinical evidence, typical dosing, and COFEPRIS regulation in Mexico.